Cholesterol Lowering and Residual Risk in Diabetes, Type 1

Clinical trial NCT05641753 · RECRUITING

Trial details

NCT number: NCT05641753
Sponsor: NYU Langone Health
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Type 1 Diabetes

Start date: 2022-12-06
Primary completion: 2027-07-01
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.